Literature DB >> 17944834

Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis.

B U Ridwan1, C J M Koning, M G H Besselink, H M Timmerman, E C Brouwer, J Verhoef, H G Gooszen, L M A Akkermans.   

Abstract

AIMS: Although probiotic prophylaxis has been suggested to prevent small bowel bacterial overgrowth, bacterial translocation and infection of pancreatic necrosis in severe acute pancreatitis, limited data are available on their antimicrobial activity. METHODS AND
RESULTS: Using the well-diffusion method, we studied the antimicrobial properties of a multispecies probiotic product (Ecologic 641) against a collection of pathogens cultured from infected pancreatic necrosis. All individual probiotic strains included in the multispecies preparation were able to inhibit the growth of the pathogens to some extent. However, the combination of the individual strains (i.e. the multispecies preparation) was able to inhibit all pathogenic isolates. Probiotic-free supernatants adjusted to pH 7 were not able to inhibit pathogen growth.
CONCLUSION: Ecologic 641 is capable of inhibiting growth of a wide variety of pathogens isolated from infected pancreatic necrosis. The antimicrobial properties are to a large extent explained by the production of organic acids. SIGNIFICANCE AND IMPACT OF THE STUDY: Ecologic 641 is currently being used in a Dutch nationwide double-blind, placebo-controlled, randomized multicentre trial in patients with predicted severe acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944834     DOI: 10.1111/j.1472-765X.2007.02260.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  9 in total

Review 1.  Health benefits of probiotics: are mixtures more effective than single strains?

Authors:  C M C Chapman; G R Gibson; I Rowland
Journal:  Eur J Nutr       Date:  2011-01-13       Impact factor: 5.614

2.  Evaluation of Probiotic Characteristics of Lactic Acid Bacteria Isolated from Two Commercial Preparations Available in Indian Market.

Authors:  Neelja Singhal; Nambaram Somendro Singh; Shilpa Mohanty; Pooja Singh; Jugsharan Singh Virdi
Journal:  Indian J Microbiol       Date:  2018-09-26       Impact factor: 2.461

Review 3.  Probiotics: progress toward novel therapies for intestinal diseases.

Authors:  Fang Yan; David Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

4.  Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial.

Authors:  David J W Knight; Dale Gardiner; Amanda Banks; Susan E Snape; Vivienne C Weston; Stig Bengmark; Keith J Girling
Journal:  Intensive Care Med       Date:  2008-12-16       Impact factor: 17.440

5.  Beneficial Effect of Bifidobacterium longum ATCC 15707 on Survival Rate of Clostridium difficile Infection in Mice.

Authors:  Bohyun Yun; Minyu Song; Dong-June Park; Sejong Oh
Journal:  Korean J Food Sci Anim Resour       Date:  2017-06-30       Impact factor: 2.622

6.  Probiotic Properties of Lactobacillus plantarum RYPR1 from an Indigenous Fermented Beverage Raabadi.

Authors:  Ruby Yadav; Anil K Puniya; Pratyoosh Shukla
Journal:  Front Microbiol       Date:  2016-10-21       Impact factor: 5.640

Review 7.  Treatment of allergic rhinitis with probiotics: an alternative approach.

Authors:  Gui Yang; Zhi-Qiang Liu; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2013-08

8.  Research on the Effect of Pediococcus pentosaceus on Salmonella enteritidis-Infected Chicken.

Authors:  Dan Lan; XinYu Xun; YaoDong Hu; NianZhen Li; ChaoWu Yang; XiaoSong Jiang; YiPing Liu
Journal:  Biomed Res Int       Date:  2020-10-10       Impact factor: 3.411

9.  Probiotic and Antifungal Attributes of Levilactobacillus brevis MYSN105, Isolated From an Indian Traditional Fermented Food Pozha.

Authors:  Rakesh Somashekaraiah; Walid Mottawea; Adithi Gunduraj; Udit Joshi; Riadh Hammami; M Y Sreenivasa
Journal:  Front Microbiol       Date:  2021-07-05       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.